6Hughes RAC,Rees JH.Clinical and epidemiological features of Guillain-Barré syndrome[J].J Infect Dis,1997,176(suppl 2):S92.
7Hughes RAC,Wijdicks EFM,Barohn R,et al.Practice parameter:Immunotherapy for Guillain-Barré syndrome[J].J Neurology,2003,61:736-740.
8Zelig G,Ohry A,Shemesh Y,et al.The rehabilitation of patients with severe Guillain-Barré syndrome[J].Paraplegia,1988,26:250-254.
9Prasad R,Hellawell DJ,Pentland B.Usefulness of the Functional Indepence Measure (FIM),its subscales and individual items as outcome measures in Guillain-Barré syndrome[J].Int J Rehabili Res,2001,24:59-64.
10Sater RA,Rostami A.Treatment of Guillain-Barré syndrome with intravenous immunoglobulin[J].Neurology,1998,51(suppl 5):S9.
